Neslihan Inal

Neslihan Inal

Auto-generated profile, based on publicly available information

Neslihan Inal

Department of Child and Adolescent Psychiatry, School of Medicine, Dokuz Eylul University

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Turkish Journal of Child and Adolescent Mental Health
Verified
Journal Article
Closed access
BŞBegüm Şahbudak
Begüm Şahbudak
NENeslihan İnal Emiroğlu
Neslihan İnal Emiroğlu

4 March 2024 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
HBHüseyin Burak Baykara
Hüseyin Burak Baykara
SGSevay Alşen Güney
Sevay Alşen Güney
SASibelnur Avcil
Sibelnur Avcil
BBBurçin Şeyda Buran
Burçin Şeyda Buran
OÇOğulcan Çıray
Oğulcan Çıray
NINeslihan Inal
Neslihan Inal
This study’s objective was to investigate the adverse effects of atypical antipsychotics (AAPs) on the metabolic, hematological, and endocrinological systems in the inpatient environment for children and adolescents with diverse psychiatric disorders. A retrospective assessment of 208 children’s and adolescents’ medical records was conducted. All patients were on AAP monotherapy. At baseline and after treatment, measurements of body weight, height, body mass index (BMI), BMI z-score, fasting blood glucose (FBG), total cholesterol, low-density lipoprotein cholesterol, triglycerides, high-density lipoprotein cholesterol, complete blood count, liver functions, thyroid functions, and prolactin levels were made. Scores from the Children’s Global Assessment Scale (CGAS) and the Health of the Nation Outcome Scales for Children and Adolescents (HoNOSCA) were preserved. The overall patient population had a mean age of 14.50 ± 2.32 years, 139 girls, and 69 boys. Of the patients, 63 (30.29%) were on risperidone (RIS), 69(33.17%) were on aripiprazole (ARI), 32 (15.39%) were on quetiapine (QUE), 42 (20.19%) were on olanzapine (OLA), and 2 (0.96%) were on clozapine (CLO). In the OLA group, the BMI and BMI z-score increased more than in the RIS, QUE, and ARI groups (P = .030, P = .014, and P = .001, respectively) (P = .001). The mean difference in CGAS and HoNOSCA between the start of antipsychotic medication and hospital discharge was statistically different for all four groups (P = .001 for all). The mean FBG levels in the OLA group increased statistically significantly (P = .013, P = .021) in contrast to the RIS group. In addition, a statistically significant difference in triglycerides across the groups was found (P = .003). According to the findings of our study, children and adolescents appear to be at a significant risk for psychotropic-induced PRL increase, weight gain, metabolic, and hematological consequences. To prevent serious health problems, a meticulous risk–benefit assessment for AAPs treatment should be done between clinicians and patients and their families.

28 April 2021 in Turkish Journal of Child and Adolescent Mental Health
Verified
Journal Article
Closed access
GÖGonca Özyurt
Gonca Özyurt
YÖYusuf Öztürk
Yusuf Öztürk
AKAli Kanik
Ali Kanik
EOElif Oral
Elif Oral
ZAZeynep Dilara Aslankaya
Zeynep Dilara Aslankaya
NINeslihan İnAl
Neslihan İnAl

21 March 2022 in Turkish Journal of Child and Adolescent Mental Health
Verified
Journal Article
Closed access
STserkan turan
serkan turan
YSYeşim Sağlam
Yeşim Sağlam
ÇEÇağatay Ermiş
Çağatay Ermiş
ŞEŞafak Eray
Şafak Eray
MTMustafa Tunctürk
Mustafa Tunctürk
NINeslihan İnAl
Neslihan İnAl

28 April 2021 in Turkish Journal of Child and Adolescent Mental Health
Verified
Journal Article
Closed access
YÖYusuf Öztürk
Yusuf Öztürk
GÖGonca Özyurt
Gonca Özyurt
VGVahdet Görmez
Vahdet Görmez
ZAZeynep Dilara Aslankaya
Zeynep Dilara Aslankaya
HBHüseyin Burak Baykara
Hüseyin Burak Baykara
AAAynur Pekcanlar Akay
Aynur Pekcanlar Akay

3 April 2025 in International Journal of Psychiatry in Clinical Practice
Verified
Journal Article
Closed access
GÖGonca Özyurt
Gonca Özyurt
YÖYusuf Öztürk
Yusuf Öztürk
ATAli Evren Tufan
Ali Evren Tufan
STserkan turan
serkan turan
ETEzgi Karagöz Tanıgör
Ezgi Karagöz Tanıgör
NINeslihan İnAl
Neslihan İnAl
The aim of this study was to compare adolescents with disruptive mood dysregulation disorder (DMDD) and comorbid attention deficit hyperactivity disorder (ADHD) and healthy control adolescents in terms of emotional intelligence (EI), emotion regulation (ER) and theory of mind (ToM) abilities. Twenty-eight adolescents with DMDD and ADHD formed the DMDD group were compared to 31 healthy controls. We administered the Affective Reactivity Index (ARI), Difficulties in Emotion Regulation Scale (DERS), Kiddie-SADS, Bar-On Emotional Intelligence Test, Faux Pas, Comprehension Test, Unexpected Outcomes Test, Faces Test and Reading Mind in the Eyes Test (RMET) as ToM skills. ARI and DERS scores were significantly elevated in the DMDD-ADHD group. The DMDD-ADHD group had significantly lower ToM skills and emotional intelligence (p < .05). When RMET, Bar-On Emotional Intelligence Test -general mood, DERS- impulsivity scores were compared between the groups, their effect sizes were as follows: 0.52, 0.81, 0.79, respectively. DERS, emotional intelligence and ToM scores were correlated in the DMDD group. In the linear regression analysis, the sole significant predictors of self-reported irritability were EI and ED total scores. This study suggests that adolescents with DMDD and ADHD face difficulties in peer relationships, mentalizing, various domains of emotional intelligence andregulation. .